MRNA Trade on Jul 17, 2020 13:53 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-Jul 13 2020: MRNA to join NASDAQ 100 Index

Technical Analysis

-SPY pattern: Consolidation
-Intraday pattern: Runner
-Other notes: N/a

Strategy / Confluence / Sizing Guide / Risk

Strategy: First test long of 92.6 level
Confluence: Half $
Strike Zone: 92.7 - 92.5
Sizing (lots + emergency): 3+2
Risk (stop / Rs): Hold below 92.5

Review / Lessons Learned

OGT but didn't get big enough its overextended and thought it would go lower.